【结 构 式】 |
【药物名称】Irindalone tartrate, LU-21-098 【化学名称】(+)-(1R,3S)-1-[2-[4-(p-Fluorophenyl)-1-indanyl]-1-piperazinyl]ethyl]-2-imidazolidinone L-(+)-tartrate 【CA登记号】104113-57-7, 96478-43-2 (free base) 【 分 子 式 】C28H35FN4O7 【 分 子 量 】558.61215 |
【开发单位】Lundbeck (Originator) 【药理作用】Anxiolytics, CARDIOVASCULAR DRUGS, Hypertension, Treatment of, PSYCHOPHARMACOLOGIC DRUGS, 5-HT2A Antagonists |
合成路线1
The synthesis has been described by Bøgesø et al. and the absolute configuration has been determined by X-ray crystallography by Jensen.
【1】 Hyttel, J.; Bogeso, K.P.; Gundertofte, K.; Boeck, V.; Christensen, A.V.; Arnt, J.; Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity. J Med Chem 1988, 31, 12, 2247. |
【2】 Jensen, B.; Structure of the (+)-tartrate of the selective 5-HT2 antagonist irindalon. Acta Cryst 1988, C44, 1602. |
【3】 Boeck, V.; Bogeso, K.P.; Hyttel, J.; IRINDALONE TARTRATE < Rec INNM >. Drugs Fut 1989, 14, 9, 859. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 21325 | 1-chloro-3-(4-fluorophenyl)indane | C15H12ClF | 详情 | 详情 | |
(II) | 21326 | 1-[3-(4-fluorophenyl)-2,3-dihydro-1H-inden-1-yl]piperazine | C19H21FN2 | 详情 | 详情 | |
(III) | 21327 | 1-(2-[4-[3-(4-fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-1-piperazinyl]ethyl)-2-imidazolidinone | C24H29FN4O | 详情 | 详情 | |
(IV) | 10355 | Diethylenediamine; Piperazine | 110-85-0 | C4H10N2 | 详情 | 详情 |
(V) | 21329 | 1-(2-chloroethyl)-2-imidazolidinone | 2387-20-4 | C5H9ClN2O | 详情 | 详情 |
Extended Information